AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AIM ImmunoTech Inc. Director's Dealing 2017

Jun 29, 2017

Director's Dealing

Opens in your device viewer

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2017-06-15

Reporting Person: Equels Thomas K. (Director, CEO / President)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-15	Options to buy Common Stock	$0.49	A	14212	Acquired	2027-06-15	Common Stock (14212)	Direct

F1: Amendment due to salary reduction as explained in the 8-K filed on June 22, 2017.